UT Health San Antonio Multispecialty and Research Hospital became the first in South Texas to use an emerging and ...

UT Health San Antonio Multispecialty and Research Hospital became the first in South Texas to use an emerging and less-invasive treatment called radiofrequency ablation on a comorbid patient with a ...

Pancreatic ductal adenocarcinoma (PDAC) is notoriously difficult to treat due to its aggressive nature and limited prognostic ...

Oncolytics Biotech Inc. (NASDAQ: ONCY) has secured FDA alignment on its pivotal Phase 3 study design for pelareorep in first-line metastatic pancreatic cancer, positioning the company to launch the ...

It's not surprising that pancreatic cancer is often referred to as a silent killer. With few early symptoms and an aggressive ...

Pancreatic duodenal resection (Whipple's Sea Surgery), which removes tumors from the head of the pancreas, is a high-level ...

A 3D micro-Light Emitting Diode (LED) device has been developed that wraps around the pancreas like octopus tentacles, ...

Dan, diagnosed with stage 4 pancreatic cancer, shares his journey to remission and insights on clinical trials and patient ...

Director, Center for Young Onset Colorectal and Gastrointestinal Cancer at Memorial Sloan Kettering Cancer Center (MSK) and Ford Family Chair, announced results that seemed almost too good to be true: ...

Researchers at the Cancer Center and Research Institute (CCRI) at the University of Mississippi Medical Center (UMMC) are ...

Pancreatic ductal adenocarcinoma (PDAC) is notoriously difficult to treat due to its aggressive nature and limited prognostic tools.